Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-γ-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatment

Cornelia Tillack, Laura Maximiliane Ehmann, Matthias Friedrich, Ruediger P. Laubender, Pavol Papay, Harald Vogelsang, Johannes Stallhofer, Florian Beigel, Andrea Bedynek, Martin Wetzke, Harald Maier, Maria Koburger, Johanna Wagner, Juergen Glas, Julia Diegelmann, Sarah Koglin, Yvonne Dombrowski, Juergen Schauber, Andreas Wollenberg, Stephan Brand*

*Corresponding author for this work

Research output: Contribution to journalArticle

176 Citations (Scopus)

Fingerprint Dive into the research topics of 'Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-γ-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatment'. Together they form a unique fingerprint.

Medicine & Life Sciences